Smith Group Asset Management, LLC Biogen Inc. Transaction History
Smith Group Asset Management, LLC
- $1.36 Trillion
- Q4 2024
A detailed history of Smith Group Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 2,000 shares of BIIB stock, worth $278,320. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$278,320% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,006Shares Held
126MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.33 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.23 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.02 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.03 Billion0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$514 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...